Company / PP&E (Net)
Immunocore Holdings plc PP&E (Net) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$11.5M
FY2025
5-year range
$7.8M / $11.5M
FY2022-FY2025
Trend
+13.6%
vs FY2024
Sector context
#93 of 193
Health Care
What the data says
At $11M, Immunocore Holdings plc's pp&e (net) ranks #93 of 193 in the Health Care sector. PP&E (Net) has increased for 3 consecutive years, from $8M in FY2022 to $11M in FY2025.
Based on SEC 10-K filings.
$11M in FY2025 with a 3-year CAGR of +13.5%.
Improved from $9M to $11M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +13.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 193 in Health CareTop 48% of 193This company $11.5M Sector average $777.6M
▼
-98.5% below sector average
Key checks
Key Insights
- Immunocore Holdings plc's pp&e (net) has grown for 3 consecutive years.
- 3-year CAGR of +13.5%, indicating consistent growth.
- In FY2025, pp&e (net) increased 13.6% year-over-year.
- Ranks #93 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.5M | +13.6% |
| FY2024 | $10.1M | +9.5% |
| FY2023 | $9.2M | +17.6% |
| FY2022 | $7.8M | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026